Xylem Inc. (XYL) intrinsic value & 10-year financials
Xylem Inc. (XYL) has a Graham intrinsic value of $107.75 per share. At $104.05 on Oct 17, 2026, the stock trades 3% below that value. Over the last 10 fiscal years revenue grew 10.2% a year to $9.0B, with an average return on invested capital of 9.2%.
- Graham intrinsic value
- $107.75
- Share price (Oct 17, 2026)
- $104.05
- Price vs Graham value
- 3% below
- Market cap
- $25.4B
- Revenue (FY2025)
- $9.0B
- Revenue growth (10-yr CAGR)
- 10.2%
- ROIC (10-yr avg)
- 9.2%
- Free cash flow (FY2025)
- $910.0M
XYL 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $9.0B | $957.0M | $3.92 | $910.0M | 13.5% | 8.1% |
| FY2024 | $8.6B | $890.0M | $3.65 | $942.0M | 11.8% | 7.0% |
| FY2023 | $7.4B | $609.0M | $2.79 | $566.0M | 8.9% | 7.6% |
| FY2022 | $5.5B | $355.0M | $1.96 | $388.0M | 11.3% | 10.9% |
| FY2021 | $5.2B | $427.0M | $2.35 | $330.0M | 11.3% | 10.9% |
| FY2020 | $4.7B | $254.0M | $1.40 | $641.0M | 7.8% | 7.2% |
| FY2019 | $5.0B | $401.0M | $2.21 | $613.0M | 9.7% | 9.8% |
| FY2018 | $5.0B | $549.0M | $3.03 | $349.0M | 13.2% | 13.5% |
| FY2017 | $4.7B | $331.0M | $1.83 | $516.0M | 11.8% | 9.2% |
| FY2016 | $3.8B | $260.0M | $1.45 | $373.0M | 10.8% | 7.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Xylem Inc. is a consistent compounder, expanding top-line revenue at 10.2% annually over the past decade.
Xylem Inc. returns on capital have been average, hovering around 9.2% ROIC over the decade.
Xylem Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Xylem Inc. is modeled at 11.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $107.75 per share.